Integrating hepatitis C testing and treatment into routine HIV care in Cameroon is feasible
Our study demonstrates the viability of integrating HCV testing and treatment into routine HIV care in Cameroon, yielding new HCV diagnoses and high cure rates. Cameroon can use this strategy to achieve HCV elimination goals, although improvements in testing uptake, diagnosis and treatment access, and laboratory capacity are needed.
Authors
- Oudou Njoya
- Charles Kouanfack (ORCID: https://orcid.org/0000-0002-0238-6205)
- Alexander Boers
- Richard Njouom (ORCID: https://orcid.org/0000-0003-3112-6370)
- Liza Coyer (ORCID: https://orcid.org/0000-0001-5830-2982)
- Guy Sadeu Wafeu (ORCID: https://orcid.org/0000-0002-6192-9580)
- Mathurin Kowo (ORCID: https://orcid.org/0000-0001-9055-6165)
- Victor Sini
- Roel A. Coutinho
- Carole Assontsa Kafack
- Gabriella Yelheen Metomo
Institutions
- Université de Yaoundé I (CM)
- Université de Dschang (CM)
- PharmAccess Group (NL)
- Central Hospital of Yaoundé (CM)
- Joep Lange Institute (NL)
- Centre Pasteur du Cameroun (CM)
- Ministry of Scientific Research and Innovation (CM)
- National Radiation Protection Agency of Cameroon (CM)
- Yaoundé General Hospital (CM)
- European Centre for Disease Prevention and Control (SE)
Publication Details
- Journal
- Journal of the International AIDS Society
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/jia2.26417
- Citations
- 2
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- Gilead Sciences
- European Centre for Disease Prevention and Control
- CHIST-ERA